期刊文献+

经涎腺投递基因疫苗的研究进展 被引量:1

暂未订购
导出
摘要 基因疫苗能够诱导机体产生较强和持久的免疫应答,制作成本低,运输、储存和使用方便,具有潜在应用价值。常规基因免疫途径有肌肉注射、皮内注射、静脉内注射、腹腔内注射、皮下注射、粘膜免疫等。涎腺作为外分泌腺体,其解剖特点特别适用于基因疫苗的投递。经涎腺投递基因疫苗是近些年涌现出的新的免疫方式,具有免疫原性强、安全性好等优点。经涎腺投递的基因疫苗不仅能够诱导体液免疫和细胞免疫,还能诱导强烈的黏膜免疫。
作者 海波 王松灵
出处 《北京口腔医学》 CAS 2006年第3期223-225,共3页 Beijing Journal of Stomatology
  • 相关文献

参考文献22

  • 1Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science, 1990, 247 (4949 Pt 1 ) : 1465-1468.
  • 2Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature, 1992 , 356(6365) : 152-154.
  • 3Ulmer JB, Donnelly J J, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein.Science, 1993 ,259(5102) :1745-1749.
  • 4Gurunathan S, Klinman DM, Seder RA. DNA vaccines:immunology, application, and optimization *. Annu Rev Immunol,2000, 18:927-974.
  • 5Yokoyama M, Zhang J, Whitton JL. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection.J Virol, 1995,69(4) :2684-2688.
  • 6Roman M, Martin-Orozco E, Goodman JS, et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med, 1997 , 3(8) :849-854.
  • 7Manickan E, Rouse RJ, Yu Z, et al. Genetic immunization against herpes simplex virus. Protection is mediated by CD4 + T lymphocytes. J Immunol, 1995, 155( 1 ) :259-265.
  • 8Fynan EF, Webster RG, Fuller DH, et al. DNA vaccines:protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A, 1993, 90(24).11478-11482.
  • 9Denis-Mize KS, Dupuis M, MacKichan ML, et al. Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther, 2000, 7(24) :2105-2112.
  • 10Goldfine ID, German MS, Tseng HC, et al. The endocrine secretionof human insulin and growth hormone by exocrine glands of the gastrointestinal tract. Nat Biotechnol, 1997, 15 (13) : 1378-1382.

二级参考文献18

  • 1O'Connell AC, Baccaglini L, Fox PC, et al. Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates. Cancer Gene Ther,1999, 6(6) :505-13.
  • 2Zheng C, Hoque AT, Braddon VR, et al. Evaluation of salivary gland acinar and ductal cell-specific promoters in vivo with recombinant adenoviral vectors. Hum Gene Ther, 2001, 12 ( 18 ) :2215-2223.
  • 3Li J, Zheng C, Zhang X, et al. Developing a convenient large animal model for gene transfer to salivary glands in vivo. J Gene Med, 2004, 6(1):55-63.
  • 4Braddon VR, Chiorini JA, Wang S, et al. Adenoassociated virusmediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo. Human Gene Ther, 1998, 9( 18 ) :2777-2785.
  • 5Delporte C, Miller G, Kagami H, et al. Safety of salivary glandadministered replication -deficient recombinant adenovirus in rats. J Oral Pathol Med, 1998, 27( 1 ) :34-38.
  • 6Wang SL, Li J, Zhu XZ, et al. Sialographic characterization of the normal parotid gland of the miniature pig. Dentomaxillofacial Radiollgy, 1998, 27(3): 178-181.
  • 7O'Connell BC, Xu T, Walsh TJ, et al. Transfer of a gene encoding the anticandidal protein histatin 3 to salivary glands. Hum Gene Ther, 1996, 7 ( 18 ) :2255-2261.
  • 8He X, Goldsmith CM, Marmary Y, et al. Systemic action of human growth homone following adenovirus-mediated gene transfer to rat submandibular glands. Gone Ther, 1998(4) , 5:537-541.
  • 9Wang S, Baum B J, Yamano S, et al. Adenoviral-mediated gene transfer to mouse salivary glands. J Dent Res, 2000, 79 ( 2 ) : 701-708.
  • 10Jemal A, Murray T, Samuels A, et al. Cancer statistics. CA Cancer J Clin, 2003, 53 ( 1 ) : 5-26.

共引文献6

同被引文献22

  • 1Liu M A. DNA vaccines: an historical perspective and view to the future[J]. Immunological Reviews, 2011, 239 : 62-84.
  • 2Viner K M, Girgis N, Kwak H,et al. B5-deficient vac- einia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals[J]. Virolo- gy, 2007,361 (2) : 356-363.
  • 3Babiuk S, Tsang C, van Drunen Littel-van den Hurk S, A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody respon- ses in sheep[J]. Bioelectrochemistry, 2007,70 (2) : 269- 274.
  • 4Li L, Saade F, Petrovsky N. The future of human DNA vaccines[J]. J Biotechnol, 2012, 162 (2-3) : 171- 182.
  • 5Hemmi H,Takeuchi O,Kawai T,et al. A Toll-like re-ceptor recognizes bacterial DNA[J]. Nature, 2000,408 (6813) :740-745.
  • 6Babiuk S, Mookherjee N, Pontarollo R, et al. TLRg-/- and TLR9+/q- mice display similar immune responses to a DNA vaccine[J]. Immunology, 2004,113 (1) : 114-120.
  • 7Tudor D, Dubuquoy C, Gaboriau V, et al. TLR9 path- way is involved in adjuvant effects of plasmid DNA-based vaccines[J]. Vaccine, 2005,23 (10) : 1258-1264.
  • 8Lladser A, Mougiakakos D, Tufvesson H,et al. DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vac- cines that promotes effective antitumor CTL immuni- ty[J]. Mol Ther,2011,19(3) :594-601.
  • 9Rathinam V A,Jiang Z, Waggoner S N, et al. The AIM2 inflammasomeis essential for host defense against cy- tosolic bacteria and DNA viruses[J]. Nat Immunol, 2010, 11(5) ..395-402.
  • 10Ishii K J, Kawagoe T, Koyama S,et al. TANK-bind- ing kinase-1 delineates innate and adaptive immune re- sponses to DNA vaccines [J]. Nature, 2008, 451 (7179) :725-729.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部